HSBC Holdings’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,500
Closed -$1.76M 2933
2025
Q4
$1.76M Sell
8,500
-32,000
-79% -$6.02M ﹤0.01% 1627
2025
Q3
$6.37M Hold
40,500
﹤0.01% 1095
2025
Q2
$6.81M Sell
40,500
-45,800
-53% -$6.8M ﹤0.01% 1029
2025
Q1
$11.8M Buy
86,300
+45,800
+113% +$5.84M 0.01% 842
2024
Q4
$4.79M Buy
+40,500
New +$4.73M ﹤0.01% 1149

Other funds holding CAH

HSBC Holdings's CAH Position: Q1 2026 in Review

HSBC Holdings reduced its Cardinal Health (CAH) stake by 15% in Q1 2026, selling an estimated $19.9M and leaving 519,844 shares worth $110M. The position accounts for 0.06% of the portfolio, ranked #309.

HSBC Holdings first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $126M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • HSBC Holdings held 519,844 shares of Cardinal Health worth $110M as of Q1 2026.
  • HSBC Holdings sold 92,629 Cardinal Health shares in Q1 2026, an estimated $19.9M.
  • Cardinal Health made up 0.06% of HSBC Holdings's portfolio in Q1 2026, its #309 holding.
  • HSBC Holdings first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Cardinal Health position peaked at $126M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.